Vera Therapeutics, Inc. (Nasdaq: VERA) announced inducement awards granted to new employees under the 2024 Inducement Plan, complying with Nasdaq Listing Rule 5635(c)(4). The awards include non-qualified stock options for 31,250 shares of Class A common stock and restricted stock units (RSUs) for 14,500 shares of Class A common stock. Each stock option has an exercise price of $39.47 per share, vesting over four years, while the RSUs will also vest over a similar period. The awards aim to attract and retain talent crucial for Vera’s growth and development in the competitive market landscape.
Vera Therapeutics Grants Inducement Awards to New Employees in Stock Options Agreement
Date:
Updated: [falahcoin_post_modified_date]